glp-1 weight loss drug news today october 2025 obesity How Supply and Demand for Drugs is Playing Out in 2026 New Daily GLP-1 Weight Loss

The societies recommend that more data are needed to decide if and when the GLP-1 RAs should be held prior to elective endoscopy

Side Effects of Other Medications: Many patients taking Wegovy for weight management may also be taking other medications to help manage the condition

Although DSM-5 diagnosis is defined through multiple behavioral criteria encompassing impaired control, social dysfunction, continued use despite harm, and tolerance or withdrawal, converging clinical and preclinical evidence indicates that the core pathological feature of SUDs is the progressive loss of control over intake (O'Brien, 2005)

Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care

Karmi et al

43 Currently, these drugs are primarily in the development and clinical trial stages, but preliminary research results have shown their potential powerful effects in reducing blood sugar and body weight